| Literature DB >> 35324858 |
Pablo Jesús Marín-García1, Yoorana Peyre2, Ana Elena Ahuir-Baraja1, María Magdalena Garijo1, Lola Llobat1.
Abstract
Honeybee populations have locally and temporally declined in the last few years because of both biotic and abiotic factors. Among the latter, one of the most important reasons is infection by the microsporidia Nosema ceranae, which is the etiological agent of type C nosemosis. This species was first described in Asian honeybees (Apis cerana). Nowadays, domestic honeybees (Apis mellifera) worldwide are also becoming infected due to globalization. Type C nosemosis can be asymptomatic or can cause important damage to bees, such as changes in temporal polyethism, energy and oxidative stress, immunity loss, and decreased average life expectancy. It causes drastic reductions in workers, numbers of broods, and honey production, finally leading to colony loss. Common treatment is based on fumagillin, an antibiotic with side effects and relatively poor efficiency, which is banned in the European Union. Natural products, probiotics, food supplements, nutraceuticals, and other veterinary drugs are currently under study and might represent alternative treatments. Prophylaxis and management of affected colonies are essential to control the disease. While N. ceranae is one potential cause of bee losses in a colony, other factors must also be considered, especially synergies between microsporidia and the use of insecticides.Entities:
Keywords: Apis mellifera; Nosema ceranae; colony losses; nosemosis
Year: 2022 PMID: 35324858 PMCID: PMC8952814 DOI: 10.3390/vetsci9030130
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Efficacy of alternative treatments against N. ceranae.
| Substance | Name | Efficacy | Reference |
|---|---|---|---|
| Plant extracts | Inhibition of | [ | |
| Inhibition of | [ | ||
| Oregano oil | 40% reduction of | [ | |
| Thymol | 41% reduction of | [ | |
| Nutraceuticals | Sulforaphane | 64% reduction of | [ |
| Naringenin | 49% reduction of | [ | |
| Carvacrol | 57% reduction of | [ | |
| Chitosan | >60% reduction of | [ | |
| Peptidoglycan | >60% reduction of | [ | |
| Probiotics |
| 90% reduction of | [ |
| 90% reduction of | [ | ||
|
| 56.8% reduction of | [ | |
| Pentadecapeptide BPC 157 | 68% reduction of | [ | |
| Other compounds | Propolis | 72% reduction of | [ |
| Veterinary drugs | Api-Bioxal® | 50% reduction of infected bees | [ |
| ApiHerb® | 50% reduction of infected bees | [ |